Posted on April 28th, 2012, 3:55 pm
MedPage Today In addition, 55.8% and 54.3% of the low- and high-dose groups, respectively, experienced at least a 40% improvement, and 31.9% and 30.7% had reached partial remission, the researchers reported in the May Annals of the Rheumatic Diseases. |